Triple-negative breast cancer (TNBC) represents approximately 15% of all breast cancer cases and is defined by the absence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor-2 (HER-2) (2, 3). This evidence concerns the gene ESR1 and breast carcinoma.